Did you know that the future of hemp- and cannabidiol (CBD)-based products could be in jeopardy? In July 2020, the European Commission issued a surprising preliminary conclusion that CBD, the non-psychoactive cannabinoid regularly used in food, wellness supplements, and skincare products, should be considered a narcotic drug under the United Nations Single Convention.

The popularity of food supplements containing cannabidiol (CBD) has risen in recent years, which prompted the EU’s Committee for Plants, Animals, Food and Feed (PAFF) to revisit the permitted consumption of hemp products in the Novel Foods (NF) catalogue.